Year archive

LungLife AI, INC — 2022 filings

All 17 regulatory filings released by LungLife AI, INC (LLAI) in 2022, sourced directly from the official regulator.

17 Filings

2022 Period

2022 filings (17)

Filing	Released	Lang
Holding(s) in Company Major Shareholding Notification	2022-12-07	English
Final Pricing Determination Regulatory Filings	2022-11-30	English
Total Voting Rights Regulatory Filings	2022-11-30	English
Block Listing Six Monthly Return Regulatory Filings	2022-11-15	English
Director share purchases Director's Dealing	2022-11-03	English
Participation in National Cancer Institute’s EDRN Regulatory Filings	2022-10-17	English
Half-year Report Interim / Quarterly Report H1 2022	2022-09-26	English
Notice of Results Report Publication Announcement	2022-09-09	English
New York State approval for commercial testing Regulatory Filings	2022-09-02	English
Block Listing Six Monthly Return Regulatory Filings	2022-05-16	English
Result of AGM Declaration of Voting Results & Voting Rights Announcements	2022-05-11	English
Publication of AR and Accounts & Notice of AGM Report Publication Announcement	2022-04-08	English
Preliminary Results Earnings Release FY 2021	2022-03-28	English
VA sites in validation study; SAB appointment Regulatory Filings	2022-03-17	English
Notice of Results Report Publication Announcement	2022-03-08	English
First patient enrolment for LungLB® study Regulatory Filings	2022-02-02	English
CPT® Code granted by American Medical Association Regulatory Filings	2022-01-04	English